10month fin/min - micro-needling and rosemary biotin & more Minoxidil 11/1/2024
The conversation discusses a hair loss treatment routine involving daily minoxidil, finasteride, micro-needling, rosemary oil, and biotin supplements. The user shares personal experiences, noting no side effects from finasteride and emphasizing the importance of a healthy lifestyle in preventing hair loss.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 23y | 1.6y Minoxidil & Biotine + 1y Finasteride + Keto | 7m Microneedling (stopped) | Progress & Temples?
A 23-year-old has been using minoxidil for 1.6 years, finasteride for 1 year, and ketoconazole shampoo, along with biotin, to treat hair loss. They noticed baby hairs and a fuller hairline but seek further improvement, especially in the temple areas, and are considering adding rosemary oil and a dermastamp.
community 4 Month Progress (Min/Fin Oral, Micro-needling + Rosemary Oil every 4 days)
The user experienced significant hair regrowth over four months using oral finasteride, oral minoxidil, micro-needling, and rosemary oil. They reported no side effects and emphasized the importance of continuing the treatment to maintain results.
community 1 month of progress on Fin, Min, and Microneedling
The user has been using finasteride, minoxidil, and microneedling consistently for one month to improve hair regrowth. They also use collagen peptides, pumpkin seed oil, vitamin D, biotin, nizoral shampoo, adenosine shampoo, caffeine topical, and rosemary oil as part of their routine.
community Turkey? Fin? Min? Fin+Min? Biotin? Keto? Saw? Dut? Nut?
The conversation humorously discusses various hair loss treatments and alternatives, including finasteride, minoxidil, and rosemary oil, with some users joking about wigs and unconventional items like roadkill. One user mentions using oral finasteride and minoxidil, topical rosemary oil, and microneedling.
community Transfeminine and wondering if minoxidil is right for me
The conversation discusses using minoxidil, finasteride, biotin, rosemary oil, and microneedling for hair regrowth, particularly around the temples. The user is seeking a permanent solution to improve hair density without ongoing intensive treatments.
Related Research
6 / 6 results
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research Androgenetic Alopecia: Therapy Update
This comprehensive review analyzes androgenetic alopecia treatments, discussing the mechanisms, costs, efficacy, and safety of FDA-approved drugs like minoxidil and finasteride, as well as newer non-FDA-approved options that have shown effectiveness across various studies.
research Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.
research Advances in hair growth
This review discusses recent advances in understanding hair growth mechanisms and reviews current and emerging therapies, but it presents no new clinical results.
research Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
This literature review reports that certain herbal remedies, such as rosemary, green tea, and ginseng, have shown promise in promoting hair growth and improving hair density, though variability and study design limitations highlight the need for more rigorous research.
research Female pattern hair loss: therapeutic update
This article reviews treatment options for female-pattern hair loss, noting the limited evidence for most therapies and emphasizing that topical minoxidil remains the only well-supported option despite a significant non-response rate.